Check out this answer from Consensus:
CRP testing is a robust and versatile tool in modern medicine, providing valuable information for diagnosing and monitoring a wide range of inflammatory conditions. From cardiovascular disease to rheumatoid arthritis and even COVID-19, understanding your CRP levels can offer critical insights into your health and guide appropriate treatment strategies.
By staying informed about CRP and its implications, you can take proactive steps in managing your health and well-being.
C-reactive protein (CRP) is a significant biomarker in the medical field, widely used to assess inflammation and tissue damage. This article delves into the importance of CRP tests, their applications, and what the results could mean for your health.
What is C-Reactive Protein?
CRP is an acute-phase protein synthesized by the liver in response to inflammatory cytokines such as interleukin 6 (IL-6), IL-1, and tumor necrosis factor (TNF)1. It was the first acute-phase protein to be described and is a sensitive marker of systemic inflammation and tissue damage.
Why is CRP Testing Important?
CRP testing is one of the most requested tests in clinical laboratories due to its broad applicability in diagnosing and monitoring various inflammatory conditions, including sepsis, trauma, and malignancies1. The test is also crucial in evaluating subclinical inflammatory processes that may underlie atherothrombotic events.
CRP and Cardiovascular Disease
CRP is a well-recognized indicator of inflammation and plays a significant role in atherogenesis. Elevated CRP levels within the reference interval are strong predictors of myocardial infarction, stroke, sudden cardiac death, and peripheral vascular disease in apparently healthy adults2. The American Heart Association and the CDC have issued guidelines for using CRP in the primary prevention of coronary heart disease and in patients with stable coronary disease or acute coronary syndromes2.
CRP in Rheumatoid Arthritis and Comorbidities
In rheumatoid arthritis (RA), CRP is routinely assessed as a marker of systemic inflammation. It also plays a role in inflammatory pathways associated with RA and promotes atherogenic effects. Elevated CRP levels in RA patients are linked to an increased risk of cardiovascular disease, diabetes, metabolic syndrome, pulmonary diseases, and depression4. Understanding the relationship between CRP levels and these comorbidities is crucial for managing RA effectively.
Advances in CRP Testing
Recent advances in analytical methods have led to the development of high-sensitivity CRP assays, which are essential for risk prediction in cardiovascular diseases. These high-sensitivity assays can detect lower levels of CRP, providing more accurate risk stratification for coronary disease2 5. Additionally, point-of-care tests for CRP, such as lateral flow tests and immunoturbidimetric assays, are being developed to offer more sensitive and convenient diagnostic tools6.
CRP and COVID-19
The measurement of CRP has gained new interest as a biomarker of severity in Coronavirus disease 2019 (COVID-19). Elevated CRP levels in COVID-19 patients are associated with severe disease and poor outcomes, making CRP testing a valuable tool in managing the pandemic1.